329
Views
0
CrossRef citations to date
0
Altmetric
Errata

Corrigendum

This article refers to:
Effects of bevacizumab and hyperthermia in a rodent model of hyperthermic intraperitoneal chemotherapy (HIPEC)

Correction to: Effects of bevacizumab and hyperthermia in a rodent model of hyperthermic intraperitoneal chemotherapy (HIPEC)

Verhulst J. Effects of bevacizumab and hyperthermia in a rodent model of hyperthermic intraperitoneal chemotherapy (HIPEC). Int J Hyperthermia 2013;29(1):62–70.

Following publication of this article, an error has been identified. The following additional text should have been published under the Declaration of Interest section:

The research data that were used by the author are part of a study supported by the Special Research Fund of Ghent University (BOF11/24J/072), under supervision of Prof. Dr. Wim Ceelen, Staff surgeon, GI Surgery, Ghent University Hospital; Associate Professor, Academic Department of Surgery, Ghent University; Director, Experimental Surgery Lab, Ghent University (Ghent University Hospital – 2K12 IC, De Pintelaan 185, B-9000 Ghent, Belgium). W. Ceelen is a senior research fellow of the Fund for Scientific Research – Vlaanderen (FWO).

The responsibility of the supervisor is limited to the data collection and processing. The supervisor dissociates himself from any conclusions on this data made by the author.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.